top of page
Working at home

Noom Expands Weight Loss Solutions with Metformin Program


Noom, the digital healthcare company renowned for its science-backed approach to behaviour change, has launched a new program integrating oral medications into its Noom Med offerings. Leading this initiative is the addition of Metformin, a widely used diabetes medication now offered as an off-label option for weight loss.


Metformin, primarily prescribed for managing type 2 diabetes, works by enhancing insulin sensitivity, reducing glucose production, and lowering appetite. These mechanisms not only help regulate blood sugar levels but also support weight loss by promoting fat burning and curbing hunger.


A New Pathway for Weight Loss

The program starts at $29 for the first month, followed by an $89 monthly subscription, with a minimum three-month commitment. This offering provides an alternative for individuals who might not meet the Body Mass Index (BMI) criteria for injectable GLP-1 medications or for those who are uncomfortable with needle-based treatments.


“This product is about more than a pill. It represents lasting change,” said Geoff Cook, CEO of Noom. “By combining medication with behaviour change, we’re creating a powerful pathway for sustained weight loss. Early successes boost motivation, making it easier to turn new habits into lifelong changes.”


Cook highlighted Metformin’s affordability as a generic medication and its accessibility for people with a lower BMI (<27) or those transitioning off GLP-1 treatments.


“We want to empower everyone, everywhere, to live better, longer,” he added.

Science-Backed Weight Loss with Metformin


Metformin will be available as a 500mg daily tablet, with personalised dosing schedules tailored for weight loss goals. To ensure safety and efficacy, patients will undergo a thorough medical review by Noom’s healthcare providers. Upon approval, medication will be delivered within seven days.


Dr. Adonis Saremi, Chief Medical Officer at Noom, explained the unique advantages of Metformin in weight loss:“Metformin has been FDA-approved for over 50 years for type 2 diabetes and is now prescribed off-label for weight loss due to its ability to boost levels of an ‘anti-hunger’ molecule. This molecule mimics the natural appetite suppression that occurs after intense exercise, making it easier for users to maintain a calorie deficit. Additionally, Metformin stabilises blood sugar and normalizes insulin levels, promoting fat metabolism.”


A Comprehensive Approach to Wellness


Noom’s Metformin program integrates seamlessly with the broader features of Noom Med, which include:


  • Telehealth Services: Asynchronous consultations with licensed healthcare providers.

  • Care Coordinator Access: Dedicated support to guide patients through their journey.

  • Noom Weight Program: Evidence-based tools for tracking progress and behavior change.

  • Premium Coaching: One-on-one sessions with certified coaches for personalized support.

  • Medication Fulfillment: Delivered through Noom’s trusted partner pharmacies.

  • Medication Companion Features: Enhanced by tools like Muscle Defense to support overall health.


The combination of medication and behavioural support underscores Noom’s commitment to providing holistic, accessible, and affordable weight loss solutions.


Accessible and Affordable Choices

With the launch of its Metformin program, Noom is broadening the spectrum of weight loss options for individuals who need effective and sustainable solutions. This expansion aims to address gaps in accessibility while offering scientifically grounded care.


Whether transitioning off GLP-1 treatments, exploring alternatives to injectable medications, or simply seeking a more affordable option, Noom’s Metformin program provides an empowering solution for a wide range of people.


For more information, visit Noom Med.

7 views0 comments

Comments


bottom of page